Работы, цитирующие эту работу

Работ: 2

Работа: MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling

1. A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer

   Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib +7

   Обзорная статьяMicroRNA in disease regulationBiomedicine & Pharmacotherapy2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.review-article.000032

2. A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer

   Hashem O. Alsaab, Bekhzod Abdullaev, Adnan Taan Alkhafaji +7

   Обзорная статьяMicroRNA in disease regulationPathology - Research and Practice2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.review-article.000094